Skip to main content
Livermore
Livermore
中文EN

Immunic, Inc.

IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001280776

No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $134.5M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Immunic, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Immunic, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Immunic, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Nagel Robert ThorvaldDirector–Sep 18, 20261
Biotechnology Value Fund L PDirector, Other: See Explanation of Responses–Sep 18, 20261
BVF Partners L PDirector, Other: See Explanation of Responses–Sep 18, 20261
BVF IncDirector, Other: See Explanation of Responses–Sep 18, 20261
Biotechnology Value Fund II LPDirector, Other: See Explanation of Responses–Sep 18, 20261
Lampert Mark NDirector, Other: See Explanation of Responses–Sep 18, 20261
Biotechnology Value Trading Fund OS LPDirector, Other: See Explanation of Responses–Sep 18, 20261
BVF Partners OS Ltd.Director, Other: See Explanation of Responses–Sep 18, 20261
BVF I GP LLCDirector, Other: See Explanation of Responses–Sep 18, 20261
BVF II GP LLCDirector, Other: See Explanation of Responses–Sep 18, 20261
BVF GP Holdings LLCDirector, Other: See Explanation of Responses–Sep 18, 20261
Ridloff ElenaDirector–Aug 10, 20261
Skerjanec SimonaDirector–Jul 7, 20262
Rudick Richard AlanDirector230,375Jul 7, 20262
Phillips Barclay ADirector–Jul 7, 20262
Neermann JoergDirector200,000Jul 7, 20262
Congleton JonDirector–Jul 7, 20262
Howson Tamar DDirector–Jun 29, 20261
Bonney Michael WDirector–Jun 29, 20261
Whaley GlennChief Financial Officer95,510Jun 29, 20261
Vitt DanielDirector29,000Jun 29, 20261
Tardio JasonPresident and COO12,512Jun 29, 20261
Lundgren ErikChief Executive Officer–Jun 1, 20261
Panzara Michael A.Chief Medical Officer–Apr 29, 20261
Nash DuaneExecutive Chairman36,032Jul 18, 20250
Muehler AndreasChief Medical Officer297,986Jul 18, 20250
Toernsen Monika MariaDirector–Jun 9, 20250
Ossipow VincentDirector–Jun 17, 20220
van den Bossche JanDirector–Jun 17, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 20, 2025 (view filing)Jun 515 daysTardio JasonPresident and COOPPurchase+12.5K$0.79+$9.88KNew position12.5K afterAmended
Jun 20, 2025 (view filing)Jun 416 daysVitt DanielCEO and DirectorPPurchase+15.0K$0.77+$11.6K+107.1%29.0K afterAmended
Jun 16, 2025 (view filing)Jun 133 daysNash DuaneExecutive ChairmanPPurchase+20.0K$0.83+$16.6K+124.8%36.0K after
Jun 5, 2025 (view filing)Jun 4-51 dayNeermann JoergDirectorPPurchase+100.0K$0.767+$76.7K+100.0%200.0K after2 lots
Jun 4, 2025 (view filing)Jun 31 dayWhaley GlennChief Financial OfficerPPurchase+45.0K$0.71+$31.9K+89.1%95.5K after
Jun 4, 2025 (view filing)Jun 31 dayRudick Richard AlanDirectorPPurchase+143.1K$0.70+$100.2K+163.9%230.4K after
Nov 13, 2024 (view filing)Nov 121 dayRudick Richard AlanDirectorPPurchase+87.3K$1.15+$100.4KNew position87.3K after
Feb 28, 2024 (view filing)Feb 262 daysVitt DanielPresident and CEOPPurchase+14.0K$1.31+$18.3K+3.7%390.9K after
May 16, 2023 (view filing)May 151 dayWhaley GlennChief Financial OfficerPPurchase+5.00K$1.75+$8.75K+24.4%25.5K after
Dec 15, 2022 (view filing)Dec 13-142 daysNeermann JoergDirectorPPurchase+82.0K$1.26+$103.0K+455.6%100.0K after2 lots
Nov 25, 2022 (view filing)Nov 232 daysNeermann JoergDirectorPPurchase+18.0K$1.39+$25.0KNew position18.0K after
Nov 23, 2022 (view filing)Nov 221 dayVitt DanielPresident and CEOPPurchase+8.00K$1.35+$10.8K+2.2%376.9K after
Nov 8, 2022 (view filing)Nov 71 dayWhaley GlennChief Financial OfficerPPurchase+5.00K$1.50+$7.50K+32.2%20.5K after
Jun 6, 2022 (view filing)Jun 33 daysVitt DanielPresident and CEOPPurchase+5.00K$3.10+$15.5K+1.4%368.9K after
Jun 6, 2022 (view filing)Jun 33 daysWhaley GlennChief Financial OfficerPPurchase+3.50K$3.05+$10.7K+38.6%12.6K after
May 16, 2022 (view filing)May 124 daysMuehler AndreasChief Medical OfficerPPurchase+3.50K$5.10+$17.9K+1.2%298.0K after
May 13, 2022 (view filing)May 121 dayWhaley GlennChief Financial OfficerPPurchase+3.00K$5.08+$15.2K+49.4%9.07K after
May 13, 2022 (view filing)May 121 dayNash DuaneExecutive ChairmanPPurchase+10.0K$5.03+$50.3K+83.1%22.0K after
Aug 11, 2021 (view filing)Aug 101 dayWhaley GlennPFO and PAOPPurchase+1.50K$9.85+$14.8K+75.0%3.50K after
Aug 11, 2021 (view filing)Aug 101 dayVitt DanielPresident and CEOPPurchase+1.00K$9.60+$9.60K+0.3%363.9K after
Aug 11, 2021 (view filing)Aug 101 dayNash DuaneExecutive ChairmanPPurchase+1.00K$9.80+$9.80K+7.1%15.0K after